Cargando…
The Cannabinoid Ligand Arachidonyl-2′-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model
There is growing need to increase the knowledge on the cannabinoid ligands in the treatment of overactive bladder. Among potential candidates, arachidonyl-2′-chloroethylamide (ACEA), a selective cannabinoid CB1 receptor agonist is proposed. The aim of this paper was to determine if ACEA, a selective...
Autores principales: | Zapała, Łukasz, Niemczyk, Grzegorz, Zapała, Piotr, Wdowiak, Artur, Bojar, Iwona, Kluz, Tomasz, Szopa, Aleksandra, Serefko, Anna, Radziszewski, Piotr, Wróbel, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963199/ https://www.ncbi.nlm.nih.gov/pubmed/36835228 http://dx.doi.org/10.3390/ijms24043820 |
Ejemplares similares
-
Effects of arachidonyl-2’-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice
por: Luszczki, Jarogniew J., et al.
Publicado: (2017) -
The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms
por: Iwaniak, Paulina, et al.
Publicado: (2023) -
Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release
por: Christiansen, Isabella Mai, et al.
Publicado: (2022) -
O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
por: Wróbel, Andrzej, et al.
Publicado: (2020) -
A Long-Term Treatment with Arachidonyl-2′-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy
por: Andres-Mach, Marta, et al.
Publicado: (2017)